APA (7th ed.) Citation

Satoshi Kawakami, Yoshinobu Nagasawa, Mihoko Hagiwara-Nagasawa, Kensuke Omura, Megumi Aimoto, & Akira Takahara. (2020). Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model. Elsevier.

Chicago Style (17th ed.) Citation

Satoshi Kawakami, Yoshinobu Nagasawa, Mihoko Hagiwara-Nagasawa, Kensuke Omura, Megumi Aimoto, and Akira Takahara. Torsadogenic Potential of a Novel Remyelinating Drug Clemastine for Multiple Sclerosis Assessed in the Rabbit Proarrhythmia Model. Elsevier, 2020.

MLA (9th ed.) Citation

Satoshi Kawakami, et al. Torsadogenic Potential of a Novel Remyelinating Drug Clemastine for Multiple Sclerosis Assessed in the Rabbit Proarrhythmia Model. Elsevier, 2020.